Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher Mullard

Showing results (101-110 of 684) with videos related to

Pageof 69
Sort By:
Nature Biotechnology|December 10, 2014
Once-yearly device takes on daily and weekly diabetes drugsAsher Mullard
Nature Biotechnology|January 10, 2015
Clinuvel's tanning agent nears approval for porphyriaAsher Mullard
Nature Reviews. Drug Discovery|October 2, 2015
FDA approves ultra-orphan drug on a 4-patient trialAsher Mullard
Nature Reviews. Drug Discovery|October 2, 2015
FDA approves female sexual dysfunction drugAsher Mullard
Nature Reviews. Drug Discovery|July 6, 2016
Reining in the supersized Phase I cancer trialAsher Mullard
Nature Reviews. Drug Discovery|February 17, 2018
Oncologists tap the microbiome in bid to improve immunotherapy outcomesAsher Mullard
Nature Reviews. Drug Discovery|December 29, 2018
Low-cost non-profit drug repurposingAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2019
Cancer stem cell candidate Rova-T discontinuedAsher Mullard
Nature Reviews. Drug Discovery|March 2, 2013
European lead factory opens for businessAsher Mullard
Nature Reviews. Drug Discovery|March 29, 2013
Molecular imaging as a de-risking tool: coming into focus?Asher Mullard
Pageof 69

Showing results (101-110 of 684) with videos related to

Sort By:
Pageof 69
Nature Biotechnology|December 10, 2014
Once-yearly device takes on daily and weekly diabetes drugsAsher Mullard
Nature Biotechnology|January 10, 2015
Clinuvel's tanning agent nears approval for porphyriaAsher Mullard
Nature Reviews. Drug Discovery|October 2, 2015
FDA approves ultra-orphan drug on a 4-patient trialAsher Mullard
Nature Reviews. Drug Discovery|October 2, 2015
FDA approves female sexual dysfunction drugAsher Mullard
Nature Reviews. Drug Discovery|July 6, 2016
Reining in the supersized Phase I cancer trialAsher Mullard
Nature Reviews. Drug Discovery|February 17, 2018
Oncologists tap the microbiome in bid to improve immunotherapy outcomesAsher Mullard
Nature Reviews. Drug Discovery|December 29, 2018
Low-cost non-profit drug repurposingAsher Mullard
Nature Reviews. Drug Discovery|November 2, 2019
Cancer stem cell candidate Rova-T discontinuedAsher Mullard
Nature Reviews. Drug Discovery|March 2, 2013
European lead factory opens for businessAsher Mullard
Nature Reviews. Drug Discovery|March 29, 2013
Molecular imaging as a de-risking tool: coming into focus?Asher Mullard
Pageof 69